Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HETRASE: Unfractioned Heparin for Sepsis
NCT00100308Phase 3Completed
- Sponsor
- Universidad de Antioquia
- Start
- Jul 2005
- Primary completion
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sepsis comparing Heparin Arm with Placebo Arm (2 arms). Primary endpoints: Change from baseline Multiple Organ Dysfunction (MOD) score at 15 days and Length of stay. Started Jul 2005; status: completed.
02
Drugs
heparin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00100308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100308.